It's no surprise the dementia app will be the first priority to commercialise and earn revenues from.
The infants app looks like it will be specialised based on age brackets, This should make pain diagnosis a lot more accurate and leaves a lower margin of assessment error.
Looks like there will be plenty of newsflow during the backend of the year, plus roadshows and additional exposure should take us multiples of where the current market cap sits. Its laughable at best.
MNQ Price at posting:
1.7¢ Sentiment: Buy Disclosure: Held
